Tamarind was selected as a technology partner for TuneLab 2.0, a collaborative AI and machine-learning drug discovery platform created by Eli Lilly. The announcement says Tamarind helps build, host, and operate the platform's inference infrastructure.
TuneLab gives participating biotechnology companies access to models trained using Lilly research data. Member companies contribute data through a privacy-preserving federated learning environment, which is operated by Rhino Federated Computing.
For TuneLab 2.0, Tamarind's role centers on user-facing workflows and scalable biomolecular model inference in separate private environments for member companies. The partnership builds on its existing work deploying model tools through secure, multi-tenant interfaces and APIs.
The article points biotechnology teams interested in TuneLab toward the program for more information. It describes an infrastructure partnership, rather than a change to how the separate federated-learning environment is operated.